Trial
NCT01105702
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
NYU Langone Health
Collaborators
Genentech, Inc.; Atlantic Health System
Condition
Brain Cancer
Intervention
Temozolomide
Why stopped
Due to slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-04